Galapagos | GLPG - Sales Revenues

Stock Price
29.00
Daily Change
-0.06 -0.21%
Monthly
3.87%
Yearly
30.16%
Q1 Forecast
27.75

Galapagos reported EUR65.3M in Sales Revenues for its fiscal quarter ending in September of 2025.





Sales Change Date
argenx SE USD 987.09M 144.59M Sep/2025
AstraZeneca USD 15.19B 733M Sep/2025
Biogen USD 2.53B 70M Sep/2025
Genmab DKK 5.86B 580M Jun/2025
Gilead Sciences USD 7.8B 700M Sep/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
GRIFOLS EUR 1.87B 20M Sep/2025
Hikma Pharmaceutical USD 829M 758M Jun/2025
Incyte USD 1.37B 310M Sep/2025
Merck EUR 5.32B 890M Sep/2025
Neurocrine Biosciences USD 794.9M 107.4M Sep/2025
Novartis USD 13.91B 144M Sep/2025
Roche Holding CHF 15.65B 274.5M Dec/2025
Sanofi EUR 11.3B 1.13B Dec/2025
UCB EUR 3.49B 129M Jun/2025
Vertex Pharmaceuticals USD 3.08B 120M Sep/2025